Tag Archives: PAP

ACA Rollout Raises Ante for Patient Access and Assistance

By Michael Christel. Amid the looming March 31 deadline for remaining uninsured and underinsured Americans to purchase health insurance mandated by the Affordable Care Act (6 million newly Medicaid-eligible individuals are expected to enroll), pharmaceutical manufacturers and other key players in this space are emphasizing the importance of enhancing access to medications for the now […]
Posted in Events, Regulatory | Also tagged , , , | Leave a comment

Patient Assistance Programs: Are They Still Relevant?

One of the key reputational assets of Big Pharma is the patient assistance program [PAP], which provides patented innovative medicines to needy patients for free or at a nominal charge – it’s the industry’s own branded version of the social safety net. But a shifting landscape of government fiscal pressures, economic decline and the erratic […]
Posted in healthcare, Regulatory | Also tagged , , , , | Leave a comment
  • Categories

  • Meta